A poorly characterized protein, historically thought to be a chaperon or enzyme, may actually be a key player in prostate ...

Adding Pluvicto to standard therapy in metastatic patients led to a radiographic PFS benefit, but questions remain about ...

Hormone treatment, also known as androgen deprivation therapy (ADT), is a cornerstone of treatment for advanced prostate cancer. Hormone treatment decreases prostate cancer growth by lowering ...

A globally-renowned prostate cancer surgeon shares the latest advancements in the field and stresses the importance of early ...

NICE recommendation of darolutamide plus hormone therapy for metastatic prostate cancer offers around 6000 patients in ...

Targeting prostate-specific membrane antigen, Lu-PSMA-617 has demonstrated clinical benefits in patients with PSMA-positive mCRPC after progression on ARPIs, including patients with and without prior ...

In a significant medical achievement, a large clinical study led by researchers from Cedars-Sinai Medical Center in the US ...

Former President Joe Biden, 82, completed a round of radiation therapy for aggressive prostate cancer. He received treatment ...

WASHINGTON (AP) — Former President Joe Biden is receiving radiation and hormone therapy as part of a new phase of treating the aggressive form of prostate cancer he was diagnosed with after leaving ...

Scientists uncover a molecular weakness that could transform prostate cancer therapy. An international team of researchers has identified a new weakness in prostate cancer cells that could enhance ...

Dr. Matthew Smith answers the question: 'Hormone Refractory Prostate Cancer?' March 16, 2009 -- Question: What is hormone refractory prostate cancer? Answer: Nearly all men respond to initial ...